These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7491370)

  • 21. The value of assays in tricyclic antidepressant therapy.
    Clower CG
    Indiana Med; 1991 Aug; 84(8):550-2. PubMed ID: 1680895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute and continuation therapy in unipolar depression: observations from the run-in phase of a maintenance trial.
    Gram LF;
    Acta Psychiatr Scand; 2008 Aug; 118(2):123-9. PubMed ID: 18384466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
    Malhi GS; Ng F; Berk M
    Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behavioral and cognitive toxicity related to elevated plasma tricyclic antidepressant levels.
    Meador-Woodruff JH; Akil M; Wisner-Carlson R; Grunhaus L
    J Clin Psychopharmacol; 1988 Feb; 8(1):28-32. PubMed ID: 3350996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Ego Impairment Index as a predictor of outcome in melancholic depressed patients treated with tricyclic antidepressants.
    Perry W; Viglione DJ
    J Pers Assess; 1991 Jun; 56(3):487-501. PubMed ID: 1865307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Combined tricyclic antidepressants and ritalin in elderly depressives].
    Naor S; Talmon Y; Guy N
    Harefuah; 1992 Oct; 123(7-8):251-2, 307. PubMed ID: 1459498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Value of amineptin in the treatment of different depressive states. Apropos of 112 cases treated as part of a national multi-centric study].
    Marie-Cardine M; Becache A; Chatelain R; Desmettre G; Gibour C; Houser M; Moene Y; Reyss-Brion MP; Saliba S; Sauret A
    Encephale; 1985; 11(4):175-7. PubMed ID: 4085404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relapse of depression during continuation treatment: three clinical vignettes.
    Nasr SJ; Gaviria M; Grupp M; Rodgers P
    J Clin Psychopharmacol; 1983 Feb; 3(1):32-4. PubMed ID: 6833521
    [No Abstract]   [Full Text] [Related]  

  • 29. [GABA levels in the plasma of patients with endogenous depression and during the treatment with thymoleptics].
    Rode A; Bidziński A; Puzyński S
    Psychiatr Pol; 1991; 25(3-4):4-7. PubMed ID: 1821976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship of antiobsessional and antidepressant effects of tricyclic antidepressants.
    Mavissakalian M; Turner SM; Michelson L; Jacob R
    Psychopharmacol Bull; 1986; 22(1):161-6. PubMed ID: 3523574
    [No Abstract]   [Full Text] [Related]  

  • 31. Tricyclic continuation and maintenance therapy in unipolar depression.
    Kleinman I; Ananth J
    Psychosomatics; 1981 Dec; 22(12):1031-6. PubMed ID: 7335840
    [No Abstract]   [Full Text] [Related]  

  • 32. [Evaluation of the effectiveness of electroshock therapy in patients with refractory depression].
    Wasik A; Leszek J; Kiejna A; Juskowiak A
    Psychiatr Pol; 1990; 24(2):111-5. PubMed ID: 2084714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retreatment for relapse following desipramine discontinuation in dysthymia.
    Friedman RA; Mitchell J; Kocsis JH
    Am J Psychiatry; 1995 Jun; 152(6):926-8. PubMed ID: 7755126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive behavior therapy, relaxation training, and tricyclic antidepressant medication in the treatment of depression.
    Murphy GE; Carney RM; Knesevich MA; Wetzel RD; Whitworth P
    Psychol Rep; 1995 Oct; 77(2):403-20. PubMed ID: 8559866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ECT and tricyclic antidepressants in the treatment of endogenous depression.
    Abrams R
    Psychopharmacol Bull; 1982 Apr; 18(2):73-5. PubMed ID: 7111610
    [No Abstract]   [Full Text] [Related]  

  • 36. Six months of desipramine for dysthymia: can dysthymic patients achieve normal social functioning?
    Friedman RA; Markowitz JC; Parides M; Gniwesch L; Kocsis JH
    J Affect Disord; 1999 Aug; 54(3):283-6. PubMed ID: 10467972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maintenance therapy for chronic depression. A controlled clinical trial of desipramine.
    Kocsis JH; Friedman RA; Markowitz JC; Leon AC; Miller NL; Gniwesch L; Parides M
    Arch Gen Psychiatry; 1996 Sep; 53(9):769-74; discussion 775-6. PubMed ID: 8792753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tricyclic antidepressants in treatment of the elderly.
    Hall RC; Beresford TP
    Geriatrics; 1984 Apr; 39(4):81-3, 86-8, 90 passim. PubMed ID: 6706120
    [No Abstract]   [Full Text] [Related]  

  • 39. Real-world role of tricyclic antidepressants in the treatment of fibromyalgia.
    Reed C; Birnbaum HG; Ivanova JI; Schiller M; Waldman T; Mullen RE; Swindle R
    Pain Pract; 2012 Sep; 12(7):533-40. PubMed ID: 22226400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Tricyclic antidepressive agents].
    Ginestet D
    Biomed Pharmacother; 1984; 38(3):126-8. PubMed ID: 6478050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.